Marleen Seiler
Copeptin for the prediction of recurrent cerebrovascular events after transient ischemic attack: results from the CoRisk study.
De Marchis G, Weck A, Audebert H, Benik S, Foerch C, Buhl D, Schuetz P, Jung S, Seiler M, Morgenthaler N, Mattle H, Müller-Stich B, Christ-Crain M, Arnold M, Katan M. Copeptin for the prediction of recurrent cerebrovascular events after transient ischemic attack: results from the CoRisk study. Stroke 2014; 45:2918-23.
Aug 28, 2014Copeptin for the prediction of recurrent cerebrovascular events after transient ischemic attack: results from the CoRisk study.
Aug 28, 2014Stroke 2014; 45:2918-23
De Marchis Gian Marco, Weck Anja, Audebert Heinrich J, Benik Steffen, Foerch Christian, Buhl Daniela, Schuetz Philipp, Jung Simon, Seiler Marleen, Morgenthaler Nils G, Mattle Heinrich Paul, Müller-Stich Beat P, Christ-Crain Mirjam, Arnold Marcel, Katan Mira
Copeptin as a marker for severity and prognosis of aneurysmal subarachnoid hemorrhage.
Fung C, De Marchis G, Katan M, Seiler M, Arnold M, Gralla J, Raabe A, Beck J. Copeptin as a marker for severity and prognosis of aneurysmal subarachnoid hemorrhage. PloS one 2013; 8:e53191.
Jan 11, 2013Copeptin as a marker for severity and prognosis of aneurysmal subarachnoid hemorrhage.
Jan 11, 2013PloS one 2013; 8:e53191
Fung Christian, De Marchis Gian Marco, Katan Mira, Seiler Marleen, Arnold Marcel, Gralla Jan, Raabe Andreas, Beck Jürgen